Patient Centered Solutions

Leverage the science of meaningful change in patient outcomes.

The measurement of patient experience is a science. Collecting valid patient experience data (PED) helps support regulatory approvals and reimbursement, and promotes market access and product differentiation. But the first challenge in PED is determining what data to capture—and the right way to capture that data—in order to draw valuable insights directly from the patient while complying with regulatory guidelines. 

Measure what matters most to patients

IQVIA’s Patient Centered Solutions (PCS) is a global leader in the science of measuring meaningful change in patient outcomes. PCS applies scientific discipline to accurately capture the patient experience and incorporate PED into trial endpoints primarily through the use of standardized questionnaires or instruments known as clinical outcome assessments (COAs).

By enriching study processes with patient-centricity, we help leading biopharma companies define smarter endpoints, gain market access and earn distinction in crowded categories.

The complete patient experience data solution

Only IQVIA offers a fully integrated, global PED solution—combining strategy and outcomes research, instrument licensing and development, expert COA design and implementation services, and clinical rater services (formerly Cronos Clinical Consulting). We partner with you from start to finish to simplify handoffs, embed regulatory expertise, and enable faster, more precise execution.

INTEGRATED APPROACH

IQVIA’s end-to-end PED workflow

The PCS team is relentlessly focused on advancing science and technologies for capturing, benchmarking and interpreting actionable data from the patient’s perspective. We support quality PED collection and COA strategy from clinical implementation to data analysis, interpretation and dissemination.

Setting the standard in patient experience data

Strategic PED consulting and outcomes research

IQVIA leads early-stage PED strategy, defining what to measure and how, applying scientific and therapeutic expertise, especially in CNS and oncology conditions. We develop study design, outcomes research, real-world evidence (RWE) generation, COA implementation, regulatory endpoint consulting and stakeholder alignment to prioritize the right measures for approvals and reimbursement. As the leader in PED services, the IQVIA PCS team guides the industry in strategically identifying what matters to most to patients.

Instrument licensing and development

We provide on-demand access to linguistically validated COAs, standardized scoring, benchmarking, and custom instrument development across languages and regions. IQVIA focuses on providing our customers with reliable, valid measurement tools across the broadest range of therapeutic areas and geographies to make instrument licensing simple, fast and easy. If your preferred instrument isn’t available in our COA Marketplace, we’ll manage the licensing process on your behalf, ensuring quick and seamless acquisition regardless of ownership.

Industry-leading COA Marketplace

With a commitment to amplifying the patient voice in clinical research, IQVIA has assembled a robust collection of clinical outcome assessments in our intuitive, easy-to-access COA Marketplace. Explore 100+ proven and respected instruments available to license for use in a wide range of healthcare-related outcomes.

COA design, eCOA and rater services

IQVIA delivers expert COA design and implementation, integration of electronic clinical outcome assessment (eCOA)  solutions, rater training and rater oversight (formerly Cronos Clinical Consulting) and intervention services based on a proprietary risk-based data monitoring (RBDM) platform. We support successful translation from protocol design to implementation of COAs in global research studies to ensure data quality and study integrity.
The right endpoint strategy is just the beginning
Forward-thinking biopharma companies are more engaged with the science of meaningful change in patient health. We bring together the expertise in the patient science, the know-how for studies, the understanding of patient preference, and the intellectual IP of how instruments work.
Our approach minimizes the impact of handoffs from one stage to the next, enabling you to go faster with greater efficiency and demonstrate ROI from PED.
Scientifically rigorous, easily interpretable and actionable patient experience data (PED) can help researchers and clinicians make pivotal decisions during the development and commercialization of interventions.
Marie E. Lamont
VP, Global Head of Patient Insights, Experience and Registry Solutions, Real World Solutions
Elan Josielewski
Senior Director, Patient Centered Solutions and General Manager, IQVIA Quality Metric
Matthew Reaney, PhD
Global Science & Analytics Lead, IQVIA PCS, Head of the PCS Institute

Capture the patient perspective with confidence

Partner with IQVIA’s Patient Centered Solutions team to execute a more precise PED strategy that meets global regulatory requirements, delivers relevant product differentiation, and applies patient insights for optimal outcomes.

Contact Us